Endovastec(SH:688016) Sou Hu Cai Jing·2025-08-26 14:07Group 1 - The core viewpoint of the article highlights the financial performance of Xinmai Medical, indicating a decline in revenue and profit for the first half of 2025 compared to the previous year [1] - Xinmai Medical reported an operating income of approximately 714 million yuan, a year-on-year decrease of 9.24% [1] - The net profit attributable to shareholders was about 315 million yuan, reflecting a year-on-year decrease of 22.03% [1] - Basic earnings per share were 2.55 yuan, down 22.02% year-on-year [1] - As of the report, Xinmai Medical's market capitalization stood at 14.6 billion yuan [1] Group 2 - The article also mentions a significant growth opportunity in the pet industry, which is projected to reach a market size of 300 billion yuan, indicating a booming sector with rising interest from listed companies [1]